Massachusetts 2024 - Prostate Cancer Facts & Statistics April 29, 2024 Download MASSACHUSETTS's 2024 Prostate Cancer Facts & Statistics SheetIncidence RatesGiven 100,000 Massachusetts men, 113.2 will be diagnosed with prostate cancer in their lifetime.6,420 will be diagnosed this year.The state is ranked #29 in the country for prostate cancer incidences. Mortality Rates18.3 in every 100,000 men will die from prostate cancer in Massachusetts.700 men in the state, this year alone.The state is ranked #42 in the country for prostate cancer deaths. CDMRP Grants in MassachusettsYear Introduced: 1997Total Grants to Date: 291Total Grand Awards Through FY 2022**: $146.8M Grant RecipientYearAmountBeth Israel Deaconess Medical Center Boston2015$1,840,716Dana-Farber Cancer Institute202020162016$1,574,670 $1,637,500 $1,606,988Brigham and Women’s Hospital, Inc.2009$1,536,877* Congressionally Directed Medical Research Programs **PCRP (Prostate Cancer Research Program) data for FY 2023 has not yet been posted CDC’s National Comprehensive Cancer Control Program (NCCCP) Funding in MassachusettsGoal: Ensure that all Massachusetts residents receive appropriate and timely screening for those cancers where strong evidence-based guidelines for screening currently exist. Goal: Increase awareness of and access to informed decision making for all Massachusetts residents about cancer screening for common cancers for which there is emerging evidence of effectiveness. Objective: By 2016, increase the number of men age 50 years and older who have discussed the risks and benefits of prostate cancer screening with their health care providers to 78%. Men at higher risk, such as those of African descent or with a family history of prostate cancer, should start discussing this issue at age 45. Baseline: Overall, 71%; White, non-Hispanics, 73%, Black, non-Hispanics, 72% Data Source: BRFSS, 2008. Strategy: Develop a Prostate Cancer Work Group to monitor emerging science regarding informed decision making and prostate cancer screening. Strategy: Promote and offer training to health care providers and other health professionals regarding informed decision-making.Strategy: Explore and identify evidence-based strategies for informed decision- making through telephone interviews and other modalities. Design, test, and evaluate a small media campaign to educate Black, non-Hispanic men regarding prostate cancer through community and faith-based partners. Strategy: Continue Community Health Worker (CHW) outreach to Black, non- Hispanic men to educate them on their risk factors and the need for informed decision-making with their health care provider. By 2016, increase the number of men age 50 years and older who have discussed the risk and benefits of prostate cancer screening with their health care providers to 78% (baseline is 71%). Men at higher risk, such as those of African descent or with a family history of prostate cancer, should start discussing this issue at age 45. Downloadable Materials Prostate Cancer by Locations More for you
Download MASSACHUSETTS's 2024 Prostate Cancer Facts & Statistics SheetIncidence RatesGiven 100,000 Massachusetts men, 113.2 will be diagnosed with prostate cancer in their lifetime.6,420 will be diagnosed this year.The state is ranked #29 in the country for prostate cancer incidences. Mortality Rates18.3 in every 100,000 men will die from prostate cancer in Massachusetts.700 men in the state, this year alone.The state is ranked #42 in the country for prostate cancer deaths. CDMRP Grants in MassachusettsYear Introduced: 1997Total Grants to Date: 291Total Grand Awards Through FY 2022**: $146.8M Grant RecipientYearAmountBeth Israel Deaconess Medical Center Boston2015$1,840,716Dana-Farber Cancer Institute202020162016$1,574,670 $1,637,500 $1,606,988Brigham and Women’s Hospital, Inc.2009$1,536,877* Congressionally Directed Medical Research Programs **PCRP (Prostate Cancer Research Program) data for FY 2023 has not yet been posted CDC’s National Comprehensive Cancer Control Program (NCCCP) Funding in MassachusettsGoal: Ensure that all Massachusetts residents receive appropriate and timely screening for those cancers where strong evidence-based guidelines for screening currently exist. Goal: Increase awareness of and access to informed decision making for all Massachusetts residents about cancer screening for common cancers for which there is emerging evidence of effectiveness. Objective: By 2016, increase the number of men age 50 years and older who have discussed the risks and benefits of prostate cancer screening with their health care providers to 78%. Men at higher risk, such as those of African descent or with a family history of prostate cancer, should start discussing this issue at age 45. Baseline: Overall, 71%; White, non-Hispanics, 73%, Black, non-Hispanics, 72% Data Source: BRFSS, 2008. Strategy: Develop a Prostate Cancer Work Group to monitor emerging science regarding informed decision making and prostate cancer screening. Strategy: Promote and offer training to health care providers and other health professionals regarding informed decision-making.Strategy: Explore and identify evidence-based strategies for informed decision- making through telephone interviews and other modalities. Design, test, and evaluate a small media campaign to educate Black, non-Hispanic men regarding prostate cancer through community and faith-based partners. Strategy: Continue Community Health Worker (CHW) outreach to Black, non- Hispanic men to educate them on their risk factors and the need for informed decision-making with their health care provider. By 2016, increase the number of men age 50 years and older who have discussed the risk and benefits of prostate cancer screening with their health care providers to 78% (baseline is 71%). Men at higher risk, such as those of African descent or with a family history of prostate cancer, should start discussing this issue at age 45.
Grant RecipientYearAmountBeth Israel Deaconess Medical Center Boston2015$1,840,716Dana-Farber Cancer Institute202020162016$1,574,670 $1,637,500 $1,606,988Brigham and Women’s Hospital, Inc.2009$1,536,877
